A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women

[1] Matsuda T(2012)Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project Jpn J Clin Oncol 42 139-147

[2] Marugame T(1999)A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan Jpn J Cancer Res 90 607-613

[3] Kamo K(2009)Screening for breast cancer: an update for the U.S. Preventive Services Task Force Ann Intern Med 151 727-737

[4] Katanoda K(2004)Risk for distant recurrence of breast cancer detected by mammography screening or other methods JAMA 292 1064-1073

[5] Ajiki W(2005)Role of detection method in predicting breast cancer survival: analysis of randomized screening trials J Natl Cancer Inst 97 1195-1203

[6] Sobue T(2009)Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study Breast Cancer Res 11 R44-540

[7] Kanemura S(2012)Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes Breast Cancer Res Treat 131 527-113

[8] Tsuji I(2013)Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series BMC Cancer 13 15-1132

[9] Ohuchi N(1991)Comparative pathology of breast cancer in a randomised trial of screening Br J Cancer 64 108-784

[10] Takei H(1988)Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial J Natl Cancer Inst 80 1125-25

[1] Matsuda T(2012)Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project Jpn J Clin Oncol 42 139-147

[2] Marugame T(1999)A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan Jpn J Cancer Res 90 607-613

[3] Kamo K(2009)Screening for breast cancer: an update for the U.S. Preventive Services Task Force Ann Intern Med 151 727-737

[4] Katanoda K(2004)Risk for distant recurrence of breast cancer detected by mammography screening or other methods JAMA 292 1064-1073

[5] Ajiki W(2005)Role of detection method in predicting breast cancer survival: analysis of randomized screening trials J Natl Cancer Inst 97 1195-1203

[6] Sobue T(2009)Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study Breast Cancer Res 11 R44-540

[7] Kanemura S(2012)Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes Breast Cancer Res Treat 131 527-113

[8] Tsuji I(2013)Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series BMC Cancer 13 15-1132

[9] Ohuchi N(1991)Comparative pathology of breast cancer in a randomised trial of screening Br J Cancer 64 108-784

[10] Takei H(1988)Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial J Natl Cancer Inst 80 1125-25